Zugriffe | |
---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 207 |
März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | August 2025 | September 2025 | |
---|---|---|---|---|---|---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 6 | 18 | 10 | 4 | 12 | 2 | 8 |
Zugriffe | |
---|---|
2021_Zirngibl_etal.pdf | 239 |